ZIOPHARM Oncology Inc (ZIOP)

NASDAQ
1.885
-0.235(-11.08%)
  • Volume:
    1,773,128
  • Bid/Ask:
    1.880/1.890
  • Day's Range:
    1.840 - 1.930

ZIOP Overview

Prev. Close
2.12
Day's Range
1.84-1.93
Revenue
-
Open
1.83
52 wk Range
1.26-5.93
EPS
-0.41
Volume
1,773,128
Market Cap
454.73M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,161,363
P/E Ratio
-
Beta
1.91
1-Year Change
-13.47%
Shares Outstanding
214,493,973
Next Earnings Date
Nov 11, 2021
What is your sentiment on ZIOPHARM Oncology Inc?
or
Vote to see community's results!

ZIOPHARM Oncology Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

ZIOPHARM Oncology Inc Company Profile

ZIOPHARM Oncology Inc Company Profile

Employees
103

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies to deliver cell- and viral-based therapies for the treatment of cancer and graft-versus-host-disease. It has developed an adenoviral vector, Ad-RTS-IL-12, which is administered intra-tumorally under the control of the RheoSwitch Therapeutic System (RTS) expression platform. Its initial clinical stage product candidate, which is being developed using the immuno-oncology platform is Ad-RTS-IL-12 + veledimex. Ad-RTS-IL-12 + veledimex uses its gene delivery system to produce interleukin-12. As of December 31, 2016, it had completed two Phase II studies evaluating Ad-RTS-IL-12 + veledimex, for the treatment of metastatic melanoma and metastatic breast cancer.

Read More
  • This is going to fly. Buy!
    0
    • 3.64 today may go up
      1
      • Will I buy it again?  Who knows.
        0
        • ZIOP $5.42 +3.83%
          0
          • sold today 4.50
            0
            • Jeff Bailey you know the drill?  You win some you lose some?
              0
            • oh I know the drill. cant win them all. these little biotech can be a crapshoot.
              0
            • Jeff Bailey Yes it is.  Same with IDRA as well.
              0
          • testing $5 soon?
            0
            • Did I say I love this stock!
              0
              • bull bull bull
                0
                • bull bull bull
                  0
                  • Holding up good I added 500 more shares.
                    0
                    • I will be the first to comment here.  Bought 1800 shares of Ziop at $4.47
                      0
                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.